ASH 2023: CAR T-Cell Therapy Safe, Effective for High-Risk DLBCL Patients
Study shows that patients at high risk due to comorbidities derive the same benefit
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.